Known targets — ChEMBL curated mechanism
ACVR1ADORA1ADORA2AADORA2BADORA3ESR1ESR2FLT3GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSC1HRH1HTR7IDH1IDH2IRAK1JAK1JAK2JAK3MEN1OPRM1P2RX3PDE5ASCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASIGMAR1SLC6A2SYKTACR1TOP2ATYK2
The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.75 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | HMGCR | P04035 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | ACLY | P53396 | 4/20 | 0.38 |
| ▸ | SLC13A5 | Q86YT5 | 4/20 | 0.38 |
| ▸ | CPT2 | P23786 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Citric Acid SCHEMBL735448 | 0.97 | ALDH1A1 (0.79) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL8647305 | 0.95 | ALDH1A1 (0.75) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL1932644 | 0.95 | ALDH1A1 (0.75) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL10561739 | 0.95 | ALDH1A1 (0.75) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL25332361 | 0.95 | ALDH1A1 (0.75) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL25331832 | 0.95 | ALDH1A1 (0.75) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL9293104 | 0.95 | ALDH1A1 (0.75) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL8032258 | 0.93 | ALDH1A1 (0.71) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL673949 | 0.92 | ALDH1A1 (0.79) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL5030701 | 0.92 | ALDH1A1 (0.79) | ALDH1A1CA4HMGCRCHRM1TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2832437-A1 | EMULSIFIED DISPERSANT AND EMULSIFIED COMPOSITION | Ajinomoto Co., Inc. (JP) | 2015-02-04 | — | — | EP | disclosed |
| EP-2010805-B1 | SEALING SYSTEM | NMC SA (BE) | 2013-06-26 | — | — | EP | disclosed |
| EP-2010805-A1 | SEALING SYSTEM | NMC S.A. (BE) | 2009-01-07 | — | — | EP | disclosed |
| WO-2007122134-A1 | SEALING SYSTEM | NMC S.A. (BE) | 2007-11-01 | — | — | WO | disclosed |
| EP-1847735-A1 | Sealing System | NMC S.A. (BE) | 2007-10-24 | — | — | EP | disclosed |
| EP-0836472-A1 | THERAPEUTIC EFFERVESCENT COMPOSITIONS | SMITHKLINE BEECHAM LABORATOIRES PHARMACEUTIQUES (FR) | 1998-04-22 | — | — | EP | disclosed |
| WO-1997002014-A1 | THERAPEUTIC EFFERVESCENT COMPOSITIONS | SMITHKLINE BEECHAM LABORATOIRES PHARMACEUTIQUES (FR) | 1997-01-23 | — | — | WO | disclosed |